Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.

× No keyword cloud information.

149 in total

1. Infection of human and rhesus lymphoblastoid cells with Herpesvirus macaca.

Authors: P R Graze; I Royston
Journal: Arch Virol Date: 1975 Impact factor: 2.574

2. Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.

Authors: Daniela Boehm; Benjamin E Gewurz; Elliott Kieff; Ellen Cahir-McFarland
Journal: Proc Natl Acad Sci U S A Date: 2010-10-05 Impact factor: 11.205

3. Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells.

Authors: D Liebowitz; J Mannick; K Takada; E Kieff
Journal: J Virol Date: 1992-07 Impact factor: 5.103

4. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.

Authors: Donna Hochberg; Tatyana Souza; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal: J Virol Date: 2004-05 Impact factor: 5.103

5. EBV LMP1: New and shared pathways to NF-κB activation.

Authors: Alfonso Lavorgna; Edward W Harhaj
Journal: Proc Natl Acad Sci U S A Date: 2012-02-02 Impact factor: 11.205

6. DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus.

Authors: D Given; E Kieff
Journal: J Virol Date: 1978-11 Impact factor: 5.103

Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.

1. Infection of human and rhesus lymphoblastoid cells with Herpesvirus macaca.

2. Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.

3. Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells.

4. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.

5. EBV LMP1: New and shared pathways to NF-κB activation.

6. DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus.

7. Epstein-Barr virus-specific RNA. III. Mapping of DNA encoding viral RNA in restringent infection.

Review 8. EBV Persistence--Introducing the Virus.

9. Identification and characterization of an Epstein-Barr virus early antigen that is encoded by the NotI repeats.

10. Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth.